Semi-Permeable Films - Medical Devices Pipeline Assessment, 2017

2017-05-03
Price :
Published : May-2017
No. of Pages : 71

Table of Contents

1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4

2 Introduction 5
2.1 Semi-Permeable Films Overview 5

3 Products under Development 6
3.1 Semi-Permeable Films - Pipeline Products by Stage of Development 6
3.2 Semi-Permeable Films - Pipeline Products by Segment 7
3.3 Semi-Permeable Films - Pipeline Products by Territory 8
3.4 Semi-Permeable Films - Pipeline Products by Regulatory Path 9
3.5 Semi-Permeable Films - Pipeline Products by Estimated Approval Date 10

4 Semi-Permeable Films - Pipeline Products under Development by Companies 11
4.1 Semi-Permeable Films Companies - Pipeline Products by Stage of Development 11
4.2 Semi-Permeable Films - Pipeline Products by Stage of Development 11

5 Semi-Permeable Films Companies and Product Overview 12
5.1 BioTime Inc Company Overview 12
5.1.1 BioTime Inc Pipeline Products & Ongoing Clinical Trials Overview 12
5.2 Covalon Technologies Ltd Company Overview 13
5.2.1 Covalon Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 13
5.3 Imbed Biosciences Inc Company Overview 19
5.3.1 Imbed Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 19
5.4 Leiden University Company Overview 20
5.4.1 Leiden University Pipeline Products & Ongoing Clinical Trials Overview 20
5.5 Stratpharma AG Company Overview 21
5.5.1 Stratpharma AG Pipeline Products & Ongoing Clinical Trials Overview 21
5.6 ULURU Inc Company Overview 22
5.6.1 ULURU Inc Pipeline Products & Ongoing Clinical Trials Overview 22
5.7 Vancive Medical Technologies Company Overview 23
5.7.1 Vancive Medical Technologies Pipeline Products & Ongoing Clinical Trials Overview 23

6 Semi-Permeable Films- Recent Developments 24
6.1 Apr 21, 2017: Henry Ford Cancer Institute Appoints Vice President, Executive Director 24
6.2 Apr 06, 2017: BioTime Forms New Subsidiary AgeX Therapeutics to Develop its Programs Focused on Human Aging 24
6.3 Apr 05, 2017: Clinical Effectiveness of Covalon's ColActive Plus to be Presented at SAWC Spring Meeting 25
6.4 Apr 03, 2017: Generous Foundation Grant to Help Start New Global Technology Development Program at Henry Ford Health System 26
6.5 Mar 28, 2017: Henry Ford Veteran Doctor Kimberly A. Brown to Help Lead Transplant Institute 27
6.6 Mar 24, 2017: Henry Ford Hospital Dermatologist Named Dermatology Chair 28
6.7 Mar 16, 2017: BioTime Reports Fourth Quarter and Fiscal Year 2016 Financial Results and Recent Corporate Accomplishments 29
6.8 Feb 21, 2017: BioTime Reports Pro Forma Gain on Deconsolidation of OncoCyte Subsidiary 31
6.9 Feb 09, 2017: Smith & Nephew Fourth Quarter Trading and Full Year 2016 Results 32
6.10 Feb 09, 2017: Smith & Nephew: Directorate Change 37
6.11 Feb 07, 2017: Henry Ford Health System Names New Chair of Neurology Department 37
6.12 Feb 07, 2017: BioTime Appoints Industry Veteran, Stephana Patton, Ph.D., J.D., as General Counsel 38
6.13 Jan 30, 2017: Covalon Posts Record First Quarter Financial Results 39
6.14 Jan 26, 2017: Henry Ford Cancer Institute Earns Distinct Level of Accreditation 40
6.15 Jan 12, 2017: Confirmation of CFO leaving Smith & Nephew 41
6.16 Jan 04, 2017: Henry Ford Health System Welcomes New President and CEO 41
6.17 Jan 03, 2017: Covalon CEO Provides Update on Anticipated Fiscal 2017 Financial Growth 42
6.18 Nov 30, 2016: Graham Baker appointed Chief Financial Officer 43
6.19 Nov 15, 2016: Henry Ford Radiation Oncology Receives 3-Year ACR Accreditation 44
6.20 Nov 03, 2016: Smith & Nephew Third Quarter 2016 Trading Report 45
6.21 Nov 03, 2016: BioTime Reports Third Quarter Results and Recent Clinical Progress 46
6.22 Oct 05, 2016: Henry Ford Health System Announces New CEO of Health Alliance Plan 48
6.23 Oct 01, 2016: Imbed Bio Recruits Jeffrey Dalsin To Lead Product Development 48
6.24 Sep 16, 2016: Covalon to Showcase IV Clear to Pediatric Specialists at the Association for Vascular Access Annual Meeting 49
6.25 Sep 09, 2016: Imbed Biosciences Secures ISO 13485:2003 Certification 50
6.26 Aug 19, 2016: Covalon Announces Third Quarter Financial Results 50
6.27 Aug 15, 2016: BioTime Announces Issuance of 31 New Patents to Strengthen its Patent Portfolio in Regenerative Medicine 51
6.28 Aug 09, 2016: Covalon Wins Another $3.5 Million Twelve Month Contract to Supply IV Clear Vascular Access Dressings to Saudi Arabia 51
6.29 Aug 09, 2016: BioTime Reports Second Quarter Results and Recent Corporate Accomplishments 52
6.30 Aug 05, 2016: UW-Madison Spinoff Gets FDA OK for Bacteria-Killing Wound Dressing 54
6.31 Aug 05, 2016: Imbed Receives FDA Clearance for Bacteria-Killing Wound Dressing 55
6.32 Jul 28, 2016: Smith & Nephew Second Quarter Trading and First Half 2016 Results 56
6.33 Jul 11, 2016: CFO to leave Smith & Nephew in early 2017 60
6.34 Jul 11, 2016: 3M Announces New Leadership Appointments 60
6.35 Jun 21, 2016: entrotech life sciences launches ChloraDerm IV Securement portfolio 61
6.36 Jun 15, 2016: Covalon Signs Distribution Agreement with Medline 61
6.37 Jun 07, 2016: Covalon Announces Participation in Ontario Government's Medical Trade Mission to Mexico 62
6.38 Jun 06, 2016: entrotech life sciences appoints former U.S. Surgeon General, Dr. Kenneth Moritsugu as Medical Director 63
6.39 Jun 01, 2016: Covalon Announces Further Expansion in the Middle East 63
6.40 May 30, 2016: Covalon Announces Second Quarter Financial Results 64
6.41 May 10, 2016: BioTime Reports First Quarter Results and Recent Corporate Accomplishments 65

7 Appendix 68
7.1 Methodology 68
7.2 About GlobalData 71
7.3 Contact Us 71
7.4 Disclaimer 71

List of Tables

Table 1: Semi-Permeable Films - Pipeline Products by Stage of Development 6
Table 2: Semi-Permeable Films - Pipeline Products by Segment 7
Table 3: Semi-Permeable Films - Pipeline Products by Territory 8
Table 4: Semi-Permeable Films - Pipeline Products by Regulatory Path 9
Table 5: Semi-Permeable Films - Pipeline Products by Estimated Approval Date 10
Table 6: Semi-Permeable Films Companies - Pipeline Products by Stage of Development 11
Table 7: Semi-Permeable Films - Pipeline Products by Stage of Development 11
Table 8: BioTime Inc Pipeline Products & Ongoing Clinical Trials Overview 12
Table 9: BioTime Films - Product Status 12
Table 10: BioTime Films - Product Description 12
Table 11: Covalon Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 13
Table 12: ColActive Plus Ag - Product Status 14
Table 13: ColActive Plus Ag - Product Description 15
Table 14: IV Clear - Product Status 15
Table 15: IV Clear - Product Description 16
Table 16: MediClear PreOp - Product Status 16
Table 17: MediClear PreOp - Product Description 17
Table 18: SurgiClear Antimicrobial Clear Silicone Surgical Dressing With Chlorhexidine And Silver - Product Status 17
Table 19: SurgiClear Antimicrobial Clear Silicone Surgical Dressing With Chlorhexidine And Silver - Product Description 18
Table 20: Imbed Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 19
Table 21: Microlyte Ag - Product Status 19
Table 22: Microlyte Ag - Product Description 19
Table 23: Leiden University Pipeline Products & Ongoing Clinical Trials Overview 20
Table 24: Skin Barrier Repair Biofilm - Product Status 20
Table 25: Skin Barrier Repair Biofilm - Product Description 20
Table 26: Stratpharma AG Pipeline Products & Ongoing Clinical Trials Overview 21
Table 27: StrataXRT - Product Status 21
Table 28: StrataXRT - Product Description 21
Table 29: ULURU Inc Pipeline Products & Ongoing Clinical Trials Overview 22
Table 30: Altrazeal exSALT - Product Status 22
Table 31: Altrazeal exSALT - Product Description 22
Table 32: Vancive Medical Technologies Pipeline Products & Ongoing Clinical Trials Overview 23
Table 33: BeneHold CHG Adhesive - Surgical Incise Film - Product Status 23
Table 34: BeneHold CHG Adhesive - Surgical Incise Film - Product Description 23
Table 35: Glossary 70

List of Figures

Figure 1: Semi-Permeable Films - Pipeline Products by Stage of Development 6
Figure 2: Semi-Permeable Films - Pipeline Products by Segment 7
Figure 3: Semi-Permeable Films - Pipeline Products by Territory 8
Figure 4: Semi-Permeable Films - Pipeline Products by Regulatory Path 9
Figure 5: Semi-Permeable Films - Pipeline Products by Estimated Approval Date 10

Filed in: Medical Device
Publisher : GlobalData